Related Articles
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model
Formulation and characterization of EGCG for the treatment of superficial bladder cancer
Comprehensive assessment of oncological outcomes in 186 patients with high‑risk non‑muscle‑invasive bladder cancer: A single institution retrospective study
Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute